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Cholesterolly packed and thicker membrane microdomains, based on the dynamic clustering
of cholesterol and sphingolipids, may help as platforms involved in a wide variety of cellular processes. The
reasons why proteins segregate into rafts are yet to be clariﬁed. The human delta opioid receptor (hDOR)
reconstituted in a model system has been characterised after ligand binding by an elongation of its
transmembrane part, inducing rearrangement of its lipidmicroenvironment [Alves, Salamon, Hruby, and Tollin
(2005) Biochemistry 44, 9168–9178]. We used hDOR to understand better the correlation between its function
and its membrane microdomain localisation. A fusion protein of hDOR with the Green Fluorescent Protein
(DOR⁎) allows precise receptormembrane quantiﬁcation. Herewe report that (i) a fraction of the total receptor
pool requires cholesterol for binding activity, (ii) G-proteins stabilize a high afﬁnity state conformation which
does not seem modulated by cholesterol. In relation to its distribution, and (iii) a fraction of DOR⁎ is
constitutively associated with detergent-resistant membranes (DRM) characterised by an enrichment in lipids
and proteins raftmarkers. (iv) An increase in the quantity of DOR⁎was observed upon agonist addition. (v) This
DRM relocation is prevented by uncoupling the receptor–G-protein interaction.
Crown Copyright © 2008 Published by Elsevier B.V. All rights reserved.1. IntroductionAlmost 20 years ago, the selective lateral conﬁnement of lipids and
proteins to discrete regions in the cell plasma membrane was
conceived as functional lipid microdomains, crucial to the function
of various biological processes [1]. Indeed, these microdomains
probably provide dynamic ﬂuid platforms that segregate membrane
components and serve to localise the requisite components with a
high concentration, allowing the speciﬁcity and the efﬁciency of
responsiveness [2,3]. Thus, direct information relating to the lipid and
protein composition of these microdomains, and the identiﬁcation
and characterisation of the driving forces involved in their sorting are
subjects of intense investigation [1,4].
The ability of lipids to exist in several phases, including gel, liquid-
ordered (lo) and liquid-disordered states (ld), and to promote
particular lipid segregation in a lipid mixture was revealed by model
membrane studies. However, rapid lateral exchanges of lipids within
this bilayer has been reported [5,6]. lo is characterised by tight acyl-
chain packing, correlatedwith extended acyl-chains and a high degree
of acyl-chain order, allowing greater hydrophobic thickness than the
average thickness of the lipid mixture. lo is observed if high concen-
trations of cholesterol (N30% mol/mol) are mixed with phospholipids
(PL) that possess saturated fatty acyl-chains [7]. Cholesterol preferen-
tially interacts with these PL and consequently promotes lo/ld phase3 561175476.
ntal.lebrun@ipbs.fr (C. Lebrun).
08 Published by Elsevier B.V. All rigseparation in particular lipid mixtures. Sphingomyelin strengthens
these domain formations, due to its acylation and its hydrogen
bonding with cholesterol [8].
The question of whether lipid rafts, depicted as small platforms in
the lo state, exist in the plasma membrane of eukaryotic cells has
received much attention over the last few years [9,10]. Indeed, cellular
plasma membranes are characterised by a relatively high cholesterol
content. They are also characterised by the presence of sphingolipids,
especially glycosphingolipid, which differ from most biological
phospholipids as they contain long, largely saturated acyl-chains.
The most compelling piece of evidence for the existence of rafts is
based on the observation that a subset of membrane components is
resistant to solubilisation with non-ionic detergents at low tempera-
tures. As expected, the puriﬁed detergent-resistant membrane frac-
tions (DRMs) are enriched in saturated lipids, sphingomyelin and
cholesterol [11] even if the conditions of solubilisation depend strongly
on the class of detergent, on the starting material (whole cells or
isolated membranes) [12–14] and on the detergent to membrane lipid
ratio [15].
The raft regions are also believed to be selective in the membrane
protein lateral distributions. Indeed, biochemical analysis of the
protein content of DRMs, isolated from several cell types, show a
striking concentration of membrane proteins modiﬁed by saturated
chain lipids, such as Thy-1 (GPI-anchored), LAT (dual palmitoylated)
and Lck (myristoylated and palmitoylated), and α subunits of the
heterotrimeric G-proteins. They appear to be targeted to rafts, as a
result of post-translational modiﬁcation with saturated lipids [2,16].hts reserved.
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thus the membrane partitioning of proteins, including signalling
molecules, has been extensively studied [3,17]. Generally, association
with DRMs was used as a criterion for estimating whether a protein
associates with lipid rafts, but how this is achieved and the speciﬁc
effects of selected lipid components remain unclear.
In this study, we focused on hDOR. This receptor appears to be a
good candidate for analysing its partitioning in plasma membrane.
Studies on reconstituted hDOR in planar-supported bilayers have
shown that binding of an agonist to hDOR induces an elongation of the
transmembrane hydrophobic part of the receptor and a rearrange-
ment of the surrounding lipid microenvironment [18–20]. These
studies suggest that hydrophobic matching between the receptor and
the lipid is a driving force for receptor trafﬁcking.
Rafts are characterised by being thicker than the surrounding
liquid-disordered regions; thus, we analysed the importance of rafts in
hDOR activity expressed in an HEK cell line (i) by measuring the
inﬂuence of membrane cholesterol content on ligand and G-protein
binding, and (ii) by analysing hDOR partitioning in various extracted
membranes and its redistribution upon ligand binding. The use of a
fusion protein of hDOR with a Green Fluorescent Protein (DOR⁎)
allowed a precise receptormembrane quantiﬁcation [21].We show, by
modulating the cholesterol content in themembrane, usingMethyl-β-
cyclodextrin (MβCD), that a fraction of DOR⁎ requires cholesterol for
activity. DRMs were then isolated and characterised by solubilisation
with cold Triton X-100 (TX-100) using various TX-100 concentrations
[14]. Our data show that a fraction of DOR⁎ appears unsolubilised by
cold TX-100. We estimated the amount of receptors constitutively
associated with the DRMs subset and upon ligand binding. Finally, we
discussed whether the observed DOR⁎ regulation by cholesterol was
dependent on its localisation in rafts.
2. Materials and methods
2.1. Chemicals
[3H]Diprenorphine (DPN) (50 Ci/mmol) and [3H]Deltorphin II (Del2) (45 Ci/mmol)
were purchased from Perkin-Elmer Life Sciences. [35S]-GTPγS (1 mCi/mmol) was
purchased from Amersham Biosciences. Non-radioactive ligands, DPDPE ([D-Pen2,D-
Pen5]-Enkephalin), were purchased from Sigma-Aldrich. Scintillation ﬂuid (Ready
protein+) was purchased from Beckman Coulter. MβCD and cholesterol (Chol) were
purchased from Sigma-Aldrich. Lipid standard (Avanti Polar Lipid) and sterol purity was
checked by TLC (Kiesegel 60 CF254, Merck). We purchased 1-Myristoyl-2-[12-[(7-nitro-
2-1,3-benzoxadiazol-4-yl)amino]dodecanoyl]-sn-Glycero-3-Phosphate (NBD-PA) from
Avanti Polar Lipids. Dimethylformamide (DMF) was purchased from SDS. Salts and
solvents were of analytical grade.
2.2. Construction of the recombinant eGFP-tagged hDOR, DNA transfections and cell culture
A recombinant human embryonic kidney cell line (HEK 293), expressing stable
hDOR fused to a T7 tag sequence at the N-terminus and to eGFP at the C-terminus, was
prepared and used in this study. pcDNA plasmids encoding hDOR was a generous gift
from Dr. B. L. Kieffer (University Louis Pasteur, Illkirch, France). First, recombinant hDOR
lacking the ATG codon was ampliﬁed by PCR, using the 5′-CACGTGTACGTAGAAC-
CGGCCCCCTCCGCCGGC-3′ sense and the 5′-GTCTAGATTAGCTAGCGGCGGCAGCGC-
CACCGCCGGG-3′ antisense primers. These primers contained an SnaBI site
(underlined) at the 5′ end of the sense primer and NheI site (underlined) at the 5′
end of the antisense primer. Second, the ampliﬁed fragment (1.1 Kb) digested by SnaBI
and NheI was inserted into the SmaI and NheI sites of the bluescsript SK+ plasmid
containing the construct SP/α7AChR-T7-eGFP-hMOR [22], in which the hMOR fragment
was replaced by a stop codon. The construct was veriﬁed by restriction enzyme analysis
and sequencing. It was then inserted into a eukaryotic expression vector pRC/CMV
(Invitrogen) at the HindIII and XbaI sites. The construct also possesses a cleavable signal
sequence (SP/α7AChR) known to target efﬁciently proteins to the plasma membrane.
The cells transfected with the plasmid were incubated at 37 °C in a humidiﬁed
atmosphere of 5% CO2 in DMEM (Dulbecco's Modiﬁed EagleMedium, Gibco), containing
10% (v/v) foetal calf serum, 50 IU/ml penicillin, 50 μg/ml streptomycin, and 400 µg/ml
geneticin (G418, Gibco BRL).
2.3. Membrane preparation
The conﬂuent cells were washed twice with ice-cold PBS, scraped off the culture
dish into ice-cold PBS, and collected by centrifugation at 1000 g for 5 min. The pelletedcells were resuspended in TE (50 mM Tris–HCl, 1 mM EDTA, pH 7.4) with protease
inhibitor (Complete Mini, Roche) at an optical density of 0.7 at λ=650 nm. The cells
were equilibrated at 4 °C for 10 min at a pressure of 30 atm in a Kontes pressure
homogeniser (Avantec) and then disrupted by nitrogen cavitation. The homogenatewas
centrifuged at 1500 g for 10 min to remove intact cells and nuclei. The supernatant was
then centrifuged at 110000 ×g for 40 min (Beckman rotor type 50.2 Ti). The pellet
resulting from the high-speed centrifugation (total membrane fraction: M) was
resuspended in TE supplemented with a protease inhibitor cocktail to adjust the
protein concentration to about 10 mg/ml.
2.4. Modiﬁcation of membrane cholesterol content
We performed two experimental procedures to deplete or load cholesterol: to
deplete cholesterol fromHEKmembranes, a volume of the total membrane fraction (M)
at a ﬁnal protein concentration of 0.75 mg/ml in TE containing protease inhibitors was
exposed to a concentration of 10 mM (D1) or 20 mM (D2) of MβCD for 1 h at 20 °C and
chilled on ice. The MβCD-treated membrane suspensions were then centrifuged in a
Beckman centrifuge using a 60Ti rotor at 110000 g to remove MβCD. The pellets were
resuspended in TE buffer resulting in D1 and D2 membranes. To load cholesterol in D2
or in M membranes, the membrane fractions (0.5 mg/ml) were incubated for 30 min at
20 °C under agitation with an equal volume of cholesterol–MβCD complexes and
washed as described above to obtain D2+ or M+, respectively. In order to prepare
cholesterol–MβCD complexes, a solution of 40 mM MβCD was ﬁrst prepared in TE.
Then, 10 ml of this MβCD solution was warmed at 70 °C and 50 µl of a cholesterol
solution (8.6 mg in 100 µl of DMF) was added, resulting in a 1/9 molar ratio of
cholesterol/MβCD. The modiﬁed membranes were then characterised for protein,
phospholipid and cholesterol content, and for binding experiments.
2.5. Binding experiments
Saturation experiments were performed using 5–20 µg of protein of M, M+, D1, D2,
and D2+ membranes, in 0.5 ml of 50 mM Tris–HCl, pH 7.4 using [3H]DPN, a non-
selective opioid antagonist, or [3H]Del2, a DOR selective agonist. Non-speciﬁc binding
was determined in the presence of 1 µM unlabelled ligand DPN or Del2. Binding assay
experiments were carried out with 100 µM Gpp(NH)p. Following a 1 h incubation
period at 25 °C, free ligandwas removed by ﬁltration usingWhatman GF/B ﬁlters. Filters
were subsequently washed three times with 10 mM ice-cold Tris–HCl buffer.
Radioactivity was measured after adding scintillation ﬂuid and by counting in a
Packard Tri-carb 2100 TR. Data were analysed with GraphPad Prism software using a
one site binding equation. For competition experiments, [3H]DPN was added at a ﬁnal
concentration of 4 nM with the indicated concentration of unlabelled competitor
DPDPE. The results were analysed using one- or two-site binding for the competitor
with GraphPad Prism software. The data were best ﬁtted to a two-site competitive
binding model, giving the proportion of each population, IC50 values and the resulting
DPDPE dissociation constants [23].
2.6. [35S]-GTPγS binding experiments
Membrane preparations (20 µg protein) were incubated in assay buffer (20 mM
HEPES, pH 7.4, 100 mM NaCl, 10 µg/ml saponin, 3 mM MgCl2, 0.1% BSA and 1 µM GDP),
containing 0.1 nM [35S]-GTPγS, in the presence or absence (basal [35S]-GTPγS binding)
of increasing concentrations of DPDPE. Following a 1 h incubation period at 30 °C, free
ligand was removed by ﬁltration usingWhatman GF/B ﬁlters. Filters were subsequently
washed three times with cold buffer. Radioactivity was measured after adding
scintillation ﬂuid and by counting in a Packard Tri-carb 2100 TR. Agonist efﬁcacy
(Emax) calculated as the maximal difference between [35S]-GTPγS binding in the
presence and absence of DPDPE, and expressed as a percentage of basal and agonist
potency (EC50) values were obtained from curve ﬁtting of dose–response curves, using
GraphPad Prism software.
2.7. Membrane detergent solubilisation
Solubilisation was assayed using the turbidity of the resulting TX-100-treated
membranes (TM). Turbidity of the suspension was measured as absorbance at 500 nm
in a Lambda UV spectrophotometer (Perkin-Elmer); the turbidity was also measured as
a function of the detergent added, because the gradual solubilisation of lipids result in
the disruption of membrane vesicles with subsequent formation of mixed micelles
greatly reducing turbidity. Thus, an aliquot of 2 ml of M (0.5, 1, and 3 mg/ml proteins,
respectively) was incubated at 4 °C under gentle agitation for 30 min with various
concentrations of TX-100 (0.1 to 1%, w/w). We veriﬁed that the degree to which
membranes were insoluble in detergent remained unaffected even if the treatment was
carried out for longer time periods (over-night). This suggests that solubilisation
reaches an equilibrium state after 10 min. In subsequent experiments, the M protein
concentration was chosen to be 3 mg/ml and then concentrations of TX-100 between
0.1% and 1% were tested.
2.8. Isolation of detergent-resistant membranes (DRMs)
After the solubilisation process, DRMs were isolated by two procedures. In
Procedure 1, TM was centrifuged at 100000 g (TL100 Beckman rotor type TLA100.3)
Fig. 1. Fluorescence of eGFP-hDOR (DOR⁎) in living HEK 293T cells. Wide-ﬁeld
microscope ﬂuorescence image of plasma membranes of HEK 293T cells observed at
room temperature, scale bar: 10 µm.
Fig. 2. Effect of cholesterol content on DOR⁎ activity in HEK 293T membranes. M
membranes are depleted in cholesterol using 10 mM or 20 mM MβCD, as described in
Materials and methods. The corresponding values for measured Chol/PL are 37% in M
(●), 13% in D1 (♦) or 8% in D2 (○). The D2 membranes are then re-complemented with
cholesterol-loaded MβCD, leading to a Chol/PL of 92% in D2+ membranes (×). A: Speciﬁc
Del2 binding is measured, as described in the Materials and methods section. Data were
analysed with a non-linear regression and were best ﬁt by a monophasic hyperbola. The
ﬁgure represents one of the three experiments performed in duplicate with similar
results. Similar data were obtained for other membrane preparations. The pharmaco-
logical parameters obtained are given in Table 1. B: Competition binding of DPDPE.
Competition displacement experiments were performed onM and D2membranes. [3H]
DPN was used at a ﬁnal concentration of 4 nM. The best ﬁt was obtained by a two-site
competitive binding model, yielding dissociation constants of 1.85±0.3 nM and 210
±22 nM; the fractions of M membranes (grey bars) and D2 (black bars) in high afﬁnity
were 28±4% and 33±4%, respectively. C: Dose–response curves for DPDPE-stimulated
[35S]GTPγS incorporation in the M and D2 membranes. Agonist efﬁcacy (Emax) was
calculated as the maximal difference between the presence and absence of DPDPE and
is expressed as a percentage of the basal value. Agonist potency (EC50) values were
obtained from curve ﬁtting of dose–response curves. The values are means±S.E.M. of
two experiments performed in duplicate.
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detergent-soluble material in the supernatant (S). S and P (in an equal volume of TE
buffer) were either characterised by their protein and lipid content, or deposited on a
density gradient. In Procedure 2, TM was deposited on a density gradient. For the
density gradient, P, S or TMmembranes were mixed with an equal volume of 70% (w/v)
sucrose solution. The resulting 40% sucrose fractionwas overlaid successively with 4 ml
of 30% sucrose and 3 ml of 5% sucrose. The gradient was centrifuged for 18 h at
200000 g in a Beckman rotor type SW 41 and 1 ml of each fraction (from F1 to F12) was
collected from the top. We determined the turbidity at 500 nm and the sucrose
percentage for each fraction. In the samples tested, we observed a light scattering band
in the low-density region (F3–5), termed LDF (LDFP, LDFS or LDFTM, respectively), and a
pellet, termed SP (SPP, SPS or SPTM respectively). Each fraction or pooled fractions (LDF,
F6–11, SP resuspended with 1 ml TE) were then analysed for quantity of proteins, lipids
and presence of DOR⁎.
2.9. Alkaline phosphatase and protein determination
Alkaline phosphatase activity was determined using p-nitrophenylphosphate
as a substrate. A 100 μl aliquot of each gradient fraction was added to 1 ml of
200 mM Tris buffer, pH 10.2 containing 4 mM MgCl2, 275 mM mannitol, and 16 mM
p-nitrophenylphosphate. After a one-hour incubation at 37 °C, the absorbance was
measured at 405 nm (Zeiss PMQII spectrophotometer). The measured absorbance in
LDFTM and SPTM were converted per unit mass of the fraction of protein to give speciﬁc
activity. Protein content wasmeasured according to Lowry et al. [24] with bovine serum
albumin as standard.
2.10. Lipid analysis
Lipids from M, S or P membranes and density gradient fractions were extracted
according to the Bligh and Dyer procedure [25]. The cholesterol content was measured
using a colorimetric method (Roche Molecular Materials) or according to the Zak
protocol [26]. Phospholipids (PL) and sphingomyelin were titrated according to the
Rouser procedure [27]. The lipid composition of the lipid extracts was characterised:
the various lipid extracts were spotted on TLC plates and submitted to migration
with chloroform/methanol/water (65:25:4, by vol.). The plate was dried and the spots
were revealed by spraying with sulphuric acid and heating at 250 °C for 15 min. The
spots were quantiﬁed using a range of lipid standards and were analysed by ImageJ
Software.
2.11. DOR⁎ quantiﬁcation as a result of ﬂuorescence measurements
DOR⁎ quantities in the membrane fractions (M, P, LDF, SP) were estimated by
steady-state ﬂuorescence measurements, carried out with a 500 SLM-Aminco spectro-
ﬂuorometer. The excitation wavelength was set to 475 nm and ﬂuorescence emission
was measured over a wavelength range of 490–550 nm. Measurements were made
with solutions of membrane fractions resuspended in TE buffer, and the protein
concentration adjusted between 0.1 and 0.6 mg/ml; this ensures that the ﬂuorescence
signals were in a measurement range of a deﬁned instrument setting. We evaluated the
speciﬁc ﬂuorescence intensity of eGFP between 500 nm and 535 nm and we calculated
the contribution of light scattering and inner ﬁlter effects on the spectra according to
the following conceptual set up [28]. According to the Rayleigh–Gans–Debye theory,
light scattering for liposome suspensions can be described by Eq. (1), in which the
parameters A(1) and A(0) are to be adjusted:
A kð Þ ¼ A 1ð Þ=k4 þ A 0ð Þ: ð1Þ
In our study, we deduced an empirical equation (Eq. (2)) from Eq. (1). Eq. (2) ﬁts the
light scattering of our membrane suspensions where k indexes the wavelength in therange between 490–500 nm and 535–550 nm. A(0), A(1) and A(2) are parameters to be
adjusted:
A kð Þ ¼ A 1ð Þ= k 490ð ÞA 2ð ÞþA 0ð Þ: ð2Þ
Calculations were performed using a non-linear regression program, GraphPad
Prism. The conﬁdence intervals for the estimated parameters corresponded to an error
risk of 5%. Accordingly, removing the baseline proﬁle from spectra between 490 nm and
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512 nm (Fig. 3B).
We carried out the following approach to correlate the DOR⁎ number in M
membranes, estimated bymeans of measurements of the receptor quantity able to bind
in high afﬁnity the antagonist DPN, with the quantity of DOR⁎ estimated by its
ﬂuorescence response. We quantitatively measured the ﬂuorescence response of DOR⁎
fractions by comparing it with a reference standard, the NBD-PA, which ﬂuoresces at a
similar wavelength range to that of the ﬂuorophore eGFP. We then used the approach
described by Lakowicz [29]. It was deﬁned by the following equation:
CeGFP ¼ eref=eeGFPð Þd /ref=/eGFPð Þd If eGFP=If refð Þd Crefð Þd n2eGFP=n2ref
 
; ð3Þ
/ is the quantum yield, If is the ﬂuorescence intensity and ε is the molar absorption
coefﬁcient of the reference (NBD-PA)[30] or DOR⁎ (eGFP) suspensions at similar
apparatus settings, n is the refractive index of the environment surrounding eGFP
(water) or the reference (chloroform). The following values were used: /ref=0.05, εref =
10000 M−1·cm−1 [30], /eGFP=0.6, εeGFP=55000 M−1·cm−1 [31]. n2eGFP and n2ref were
the refractive indexes of water and chloroform [32].
3. Results
We prepared a recombinant human embryonic kidney cell line,
which expresses a stable form of hDOR fused to eGFP in Cterm and can
be detected by ﬂuorescence. We veriﬁed by optical microscopy that
the recombinant hDOR (DOR⁎) exhibited mainly plasma membrane
localisation (Fig. 1). The aim of our study was to investigate the role of
rafts in DOR⁎ activity using only membrane preparations preventing
any events induced by cellular processes (i) by analysing the inﬂuence
of membrane cholesterol content on DOR⁎ ligand binding capacities
and (ii) by measuring DOR⁎ partitioning in separated membrane
fractions.
3.1. DOR⁎ functionality and its membrane quantiﬁcations
We tested the functionality of DOR⁎ (Fig. 2A, B, C) by examining its
ability to bind its ligands in the membrane preparations: A receptor
amount of 6.5 pmol/mg and a Kd of 1.3 nM were determined by the
DPN binding experiments (Table 1). Within the agonist, Del2,
concentration range explored (Fig. 2A, Table 1), a single population
corresponding to a pool of 2.1 pmol/mg of the receptor was observed
to be in the high afﬁnity state (Kd=1.9 nM). Competition curves for
binding between [3H]DPN and unlabelled DPDPE, another speciﬁc
DOR full agonist, and the data obtained by modelling the curves with
two populations are given in Fig. 2B. Also, the proportion of sites in the
high afﬁnity state (28%) is consistent with the percentage of the total
receptor pool labelled by [3H]Del2 (Table 1). Our ﬁndings indicated
that the high binding afﬁnities of these three ligands are consistent
with those reported previously for the wild-type receptor [33,34].
Steady-state ﬂuorescence measurements allowed the quantiﬁca-
tion of the receptor concentrations in the basal membranes or various
membrane fractions obtained by solubilisation preparations. To
ﬁnalize this protocol, for calibrating the eGFP of hDOR ﬂuorescence
in membranes, we used the emission spectra from a range of in-
creasing protein concentrations of M (0.1 to 0.6 mg/ml) (Fig. 3A). ForTable 1
Binding parameters of DOR⁎ expressed in M membranes in which cholesterol content was
Samples Chol/
PL (%)
Diprenorphin (DPN) Deltorphin II (Del2)
− GppNHp
Bmax (pmol/mg) Bmax (% of M) Kd (nM) Bmax (pmol/mg) Bm
M 37±3 6.5±0.5 100 1.3±0.4 2.1±0.3 10
D1 13±2 3.0±0.3 46±8 1.2±0.3 1.3±0.2 6
D2 8±0.5 2.6±0.4 40±8 1.6±0.6 1.0±0.1 4
D2+ 92±16 6.8±0.6 104±18 2.2±0.5 2.1±0.4 10
M+ 64±10 6.0±0.6 92±15 2.0±0.6 1.9±0.3 9
Data correspond to mean values±S.E.M. of three doubled independent experiments.
n.d.: not determined.
a Percentage of Bmax value evaluated from the sample M as reference.
b Percentage of Bmax value evaluated from the total receptor pool calculated by [3H]DPNeach suspension, ﬂuorescence intensity, ΔF, was plotted as a function
of the amount of proteins (Fig. 3C). This demonstrates a proportional
relation between ΔF and the protein concentration (4.15 a.u./mg of M).
We estimated the concentration of the eGFP ﬂuorophore using NBD-
PA as the standard ﬂuorescent reference [30]: we evaluated a value of
8±3 pmol/mg. It is in a same range of that determined by pharma-
cological binding of DPN. Furthermore, assuming a value of 6.5 pmol/
mg of membrane proteins obtained in the antagonist binding mea-
surements for active DOR⁎ receptor (Table 1), the ΔF values can be
related to a number of initial receptors (Fig. 3C). We calculated a slope
of 0.64 a.u./pmol of receptor. This result allowed us to quantify DOR⁎
in the various membrane fractions studied.
3.2. Modulation of DOR⁎ binding activity by the membrane cholesterol
content
We examined the inﬂuence of cholesterol content on DOR⁎ activity
by measuring Diprenorphine and Del2 binding or DPN displacement
by DPDPE, in membranes in which the cholesterol content was
modiﬁed. Above all, we veriﬁed using eGFP ﬂuorescence quantiﬁca-
tion that the membrane receptor content was unchanged after MβCD
treatment (Fig. 3D). An enrichment in cholesterol (Table 1: M+ with
Chol/PL=64% mol/mol) did not modify the binding parameters (Bmax
and Kd) of both ligands. By contrast, by increasing the MβCD concen-
tration, the cholesterol content progressively decreased (Fig. 2A,
Table 1). Table 1 gives the dissociation constants (Kd) and the Bmax
values obtained with the two ligands in MβCD-treated membranes
(D1 and D2) and in non-treated membranes (M). Comparison of Bmax
values, obtained within the range of concentrations tested with Del2
(1 pmol/mg) and DPN (2.6 pmol/mg) in D2 membranes, suggests that
38% of the receptors are in a high afﬁnity state. When competition
displacement experiments were performed on D2 membranes, with
[3H]DPN as ligand and DPDPE as competitor (Fig. 2B), the data ob-
tained with D2 were consistent with two populations with similar
Ki values and proportionally similar (33%) to that obtained with
M membranes. These data, consistent with the results obtained by
[3H]Del2 binding, suggest that the cholesterol content modulates the
low and the high afﬁnity state. However, evenwith a very low Chol/PL
ratio (8%), 40% and 47% of the total receptor pool remains able to
bind DPN and Del2 respectively, with very similar binding afﬁnities.
Moreover, the depleted membranes were re-complemented in
cholesterol (D2+) to check whether the effects of MβCD treatment
on receptor binding could be reversed. In D2+, the receptor binding
factors and responses were fully restored.
We also analysed the inﬂuence of G-protein coupling on Del2
binding in M and D2 by adding GppNHp in binding assays (Table 1).
The data shows that the pool of receptors recognised by Del2, within
concentration range explored, corresponds to 1.6 pmol/mg and
0.3 pmol/mg, i.e. 25% and 5% of the total receptor pool (6.5 pmol/
mg) in M and D2, respectively. These data show that the fraction of
receptors in high afﬁnity state (labelled by [3H]Del2) is, as expectedmodiﬁed using MβCD
+GppNHp
ax
a (%) Bmaxb (%) Kd (nM) Bmax (pmol/mg) Bmaxa (%) Bmaxb (%) Kd (nM)
0 32±8 1.9±0.7 1.6±0.2 100 25±5 5.5±1.8
2±15 20±4 2.0±0.4 n.d. n.d. n.d. n.d.
7±11 15±2 5.5±1.8 0.3±0.1 18±8 5±3 2.0±1.1
0±13 30±10 1.8±0.8 n.d. n.d. n.d. n.d.
0±15 29±10 1.0±0.6 n.d. n.d. n.d. n.d.
in M samples (6.5 pmol/mg).
Fig. 3. Quantiﬁcation of DOR⁎ in M membranes. (A) Fluorescence spectra of eGFP of M
membranes at 0.25 mg/ml, 0.35 mg/ml, 0.5 mg/ml, and 0.6 mg/ml (from top to bottom).
(B) Fluorescence spectrum of eGFP of M membranes at 0.6 mg/ml (black line) and
baseline ﬁt obtained by non-linear regression using Eq. (2) (dotted line). Corrected eGFP
ﬂuorescence spectra (grey line) were obtained by removing the ﬁt to the original
spectra. The resulting maximum ﬂuorescence intensity (ΔF) was measured at 512 nm.
(C) Evolution of ΔF as a function of the protein concentration. A proportional relation of
ΔF with protein concentration is obtained (0.45 a.u./mg of M membranes). Assuming a
Bmax of 6.5 pmol/mg of M membranes for Diprenorphine, ΔF can be expressed as a
function of DOR⁎ binding capacity with a slope of 0.64 a.u./pmol. (D) Fluorescence
spectra of native M membrane (grey sinks), after cholesterol depletion (light grey), or
after cholesterol re-complementation (black). Fig. 4. Solubilisation and characterisation of protein, PL and cholesterol contents of
membraneswith increasing TX-100 concentrations. A:Mmembraneswere treatedwith
aliquots of a concentrated solution of TX-100 at 4 °C with constant stirring for 10 min.
The turbidity of TM was measured at an absorbance of 500 nm. Solubilisations were
performed with 3 mg/ml (●), 1 mg/ml (○) and 0.5 mg/ml (Δ) of M membranes.
B: M membranes (3 mg/ml) were treated with various concentrations of TX-100 for
30 min at 4 °C. The resulting TMmembranes were sedimented by ultracentrifugation at
100000 ×g for 20 min at 4 °C (Procedure 1). Each pellet (P) was resuspended in an equal
volume of TE buffer and the phospholipid (○), protein (●) and cholesterol (Δ) contents
were measured. The corresponding PL/protein ratios expressed in nmol of PL per mg of
proteins are given in Table 2.
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of cholesterol in the membranes (Table 1: M→D2) caused 82% of
inhibition of the high afﬁnity state receptor pool.
Moreover, incorporation of the non-hydrolysable GTP-analog [35S]-
GTPγS in M, D1 and D2membranes was used to monitor the inﬂuence
of membrane cholesterol depletion on agonist-induced stimulation.
The ability of DPDPE to activate G-protein is decreased in D1 (30% ofthe Emax value of M) and D2 (50% of the Emax value of M) without
signiﬁcantly affecting EC50 values (Fig. 2C). Also, the lower Emax values
in D1 and D2 are in accordance with fewer numbers of receptors in a
high afﬁnity state.
3.3. Solubilisation, isolation and characterisation of detergent-resistant
membranes (DRMs)
3.3.1. Membrane detergent solubilisation
We investigatedwhetherDOR⁎waspartially localised in cholesterol-
rich microdomains; thus, we analysed its partitioning between DRMs
and solubilised membranes (N-DRMs) after cold TX-100 treatments.
Assuming that the extent of membrane solubilisation depends essen-
tially on the detergent to lipid ratio, the solubilisation process was
analysed by measuring changes in turbidity as a function of the
detergent added (Fig. 4A). As expected, the ability of TX-100 to solubilise
was enhanced with increasing detergent concentrations or by lowering
membrane concentrations. However, in contrast to SDS solubilisation
of membranes or cold TX-100 solubilisation of liposomes [35], the
suspensionsnever completely cleared, even at thehighest concentration
of detergent.
3.3.2. Isolation of membrane fractions and characterisation
We compared DRMs obtained from two procedures using various
TX-100 quantities. In Procedure 1, treated membranes (TM) were
centrifuged resulting in a pellet (P) and supernatant (S), correspond-
ing to unsolubilised membrane and soluble material, respectively.
Each fraction was then subjected to a discontinuous sucrose density
Table 2
Measured PL/protein, Chol/PL and SM/PL ratios in samples obtained by fractionation of TM
TX-100 (%) PL/protein (nmol/mg) Chol/PL (% mol/mol) SM/PL (% mol/mol)
Samples: 0 0.1 1 0 0.1 0.3 1 0 0.1 0.5
M 350±60 37±3 2.4±0.5
P 188±32 42±7 58±5 71±6 109±11 1.3±0.3 13±3.0
S 368±62 826±140 19±2 23±2 27±3 0 0
LDFTM 4670±800 1710±290 65±6 73±7 66±6 5.8±0.6 11.5±2.0
(F6–11)TM 441±70 423±72 35±3 46±4 46±5 2.4±0.5 1.4±0.3
SPTM 158±26 34±6 41±4 55±5 50±5 5.1±1.0 8.4±1.6
Data correspond to mean values±S.E.M. of three independent experiments.
Fig. 5. Lipid and protein contents in samples obtained by fractionation of TM using 0.1%
TX-100. TM (grey bars) was obtained according to M membrane treatments (3 mg/ml)
with 0.1% TX-100. After the solubilisation procedure, TM was separated in two samples.
In the left part of the panel according to Procedure 1: the ﬁrst sample was centrifuged at
100000 ×g for 20 min at 4 °C giving rise to a pellet P (black bars) and a supernatant S
(white bars), in which protein (A), phospholipid (B) and cholesterol (C) contents were
measured. In the right part of the panel, P and S were then subjected to a density
gradient leading to LDFP, (F6–11)P, SPP and to LDFS, (F6–11)S, SPS respectively. According to
Procedure 2: the second sample was directly subjected to the same density gradient,
resulting in LDFTM, (F6–11)TM and SPTM, depicted by the corresponding grey bars which
characterise their lipid and protein contents. Data are means±S.E.M. of two
experiments performed in duplicate.
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TM membranes were subjected directly to a discontinuous sucrose
density gradient. The ﬁrst step of Procedure 1 is classically used to
estimate solubilisation of HEK membranes by measuring the amount
of phospholipids and protein present in P and S. The data indicated a
progressive loss of membrane phospholipids in P (Fig. 4B). A large
proportion of membrane phospholipids were solubilised (90% PL) at
the highest concentration of detergent used (1%). However, the results
for membrane proteins show efﬁcient solubilisation of protein (20%)
at low concentrations of TX-100 (0.1%), beyond which greater concen-
trations of detergent cause only a weak increase in the extent of
solubilisation: 70% of the protein content remained in the pellet. The
resulting PL/protein ratio (Table 2) in S increases with increasing TX-
100 concentration (368 and 826 nmol/mg for 0.1% and 1%, respec-
tively). By contrast, the ratio decreases in P: with 1% TX-100 treatment,
the PL/protein ratio was signiﬁcantly lower (Table 2: 42 nmol/mg)
than the initial value (350 nmol/mg), indicating that the samples
obtained in pellets under these conditions are very poor in lipids.
We then submitted P to a sucrose gradient, and observed a light
scattering band in the low-density region (LDFP) and a sucrose-pellet
(SPP), under all solubilisation conditions. LDFP, (F6–11)P and SPP were
collected and individually assayed for protein and lipid content. The data
obtained with 0.1% TX-100 are shown in Fig. 5A. We noted that 65% of
TM protein content was collected in SPP, but only 2.5% was collected in
LDFP. A similar amount of lipid was recovered in LDFP, (F6–11)P and SPP.
(F6–11)P was subjected to a second ultracentrifugation step to explain the
presence of insoluble material in these fractions, usually attributed to
solublematerial. In this case, lipids and proteins are found exclusively in
the pellet (data not shown). Therefore, (F6–11)P contains insoluble
membranes, which probably differ from LDFP and SPP in their intrinsic
density.
We subjected the S sample to the sucrose gradient: no pellet (SPS)
was observed (Fig. 5A). Only a small band was sometimes observed in
LDFS (PLb5%) (Fig. 5B, C). As expected, proteins and lipids weremostly
recovered in (F6–11)S.
We compared Procedure 1 to one more classically used to isolate
DRMs: Procedure 2. In this case, a light scattering band in LDFTM and
SPTM was observed with various TX-100 concentrations. Proteins were
mainly present in SPTM (72%), whereas only 4% was present in LDFTM
(Fig. 5A). By increasing TX-100 concentrations, we observe a pro-
gressive loss of protein and lipid in the SPTM, whereas the lipid and
protein content increase in (F6–11)TM (data not shown). In LDFTM, a
near constant protein amount was observed; however, the PL/protein
ratio (Table 2) decreased with increasing TX-100 concentrations (from
to 4670 to 1710 nmol/mg with 0.1% and 1% TX-100, respectively),
indicating a progressive loss of lipids in LDFTM. As expected by fraction
localisation across the gradient, LDFTM has a higher PL/protein ratio
than SPTM (≈158–34 nmol/mg) and even that of M membranes
(350 nmol/mg). M membranes were regrouped in the sucrose-pellet,
if subjected to this sucrose gradient.
We analysed the P, S and the TM gradient fractions for the presence
of raft protein and raft lipid markers. This analysis was carried out to
further characterise the speciﬁcity of detergent resistance in relationto the signiﬁcance of rafts. The presence of raft proteins markers, such
as the acylated protein Alkaline phosphatase (PLAP) known to be
selectively enriched in rafts [36], was detected in LDFTM and in SPTM
(Fig. 6). The resulting speciﬁc activities of samples solubilised with
0.1% TX-100 were 1.7 a.u./mg and 0.3 a.u./mg for LDFTM and SPTM,
respectively, suggesting that LDFTM is enriched in PLAP.
The distribution of cholesterol (Fig. 5) and the corresponding Chol/
PL ratios are given in Table 2. At 0.1% of TX-100, cholesterol is almost
exclusively found in P. Also, Chol/PL values in P (58%), LDFTM (65%),
and SPTM (41%) were higher than those measured in S (19%) or in M
membranes (37%). Chol/PL valueswere greaterwith increasing TX-100
Fig. 6. Distribution of PLAP in the sucrose gradient fractions of TM membranes. TM
membranes were obtained by treatment of M membranes with 0.1% (●), 0.3% (○) and
0.5% (Δ) of TX-100. TM was subjected to a density gradient (Procedure 2). Each gradient
fraction was assayed for protein content and for alkaline phosphatase activity. The
resulting speciﬁc activities were 1.7±0.3 a.u./mg and 0.3±0.1 a.u./mg in LDFTM and SPTM,
respectively.
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neously solubilised by cold TX-100. In all cases, LDFTM was more
enriched with cholesterol than SPTM. We carried out an extensive
analysis by determining the composition of lipid species in several
fractions obtained under various extraction conditions (0.1% TX-100:
Fig. 7A and 0.5%: Fig. 7B). First, P, LDFTM and SPTM displayed similar
compositions. We observed the following patterns of solubility: PS, PG
and SM (sphingomyelin) appeared to beweakly soluble (only observedFig. 7. Characterisation of the lipid composition in samples obtained by fractionation of
TM. M membrane solubilisations were performed with 0.1% (A) or 0.5% (B) of TX-100. S
and P membranes were obtained by sedimentation of TM, as described in the Materials
and methods section (First step of procedure 1). TM was solubilised with 0.1% (A) or
0.5% (B) of TX-100 (Procedure 2). TM was then subjected to the density gradient, and
LDFTM, (F6–11)TM and SPTM were subsequently collected after fractionation. The lipid
compositions were obtained by a TLC analysis of each sample. The quantiﬁcation of lipid
species was performed by measuring the intensity of each spot compared with the
corresponding lipid standard. The data are expressed as a percentage of the total
amount of lipids in a given fraction. Data are means±S.E.M. of three experiments. PE
(phosphatidylethanolamine), PG (phosphatidylglycerol), PS (phosphatidylserine),
PI (phosphatidylinositol), PC (phosphatidylcholine), and SM (sphingomyelin).in P) in cold TX-100. PI-PC was in turn more soluble than PE (an
increase in the TX-100 concentration results in greater amount of PI-PC
in S), consistentwith previous studies [37,38] (Fig. 7A, B). Furthermore,
amarked difference between (LDF/SP)TM and solublematerial (S)was a
higher SM/PL value, which increases with increasing TX-100 concen-
trations (Table 2). By contrast, the data obtained with (F6–11)TM in
comparison with S conﬁrmed reported contamination by insoluble
material in (F6–11)TM, and in this way, the difﬁculty encountered in
analysing this sample.
3.4. hDOR partitioning
We investigated DOR⁎ partitioning in membranes using various
TX-100 concentrations. Assuming that eGFP has a similar environment
in M as in DRMs (P, LDF, SP), DOR⁎ can be quantiﬁed by eGFP analysis
(Fig. 3). However, soluble fractions of membranes cannot be quantiﬁed
by the same procedure. Thus, the balance in the distribution of DOR⁎
was obtained by comparingΔF values of deposited membranes and its
ΔF values that correspond to the insoluble membrane fractions
We compared the ﬂuorescence intensities of samples S and P ob-
tained by sedimentation of membranes treated with various concen-
trations of detergent. The data showed an increase of the ﬂuorescence
intensity in S with increasing TX-100 concentrations, correlatedwith a
decrease of the ﬂuorescence in P, indicating progressive DOR⁎
solubilisation. However, no clear difference was observed between
the ﬂuorescence of fractions with 0.5% TX-100 and samples with
concentrations of TX-100 above 0.5%; this correlates with the protein
solubilisation process (Fig. 2) and suggests that DOR⁎ solubilisation is
maximal with about 0.5% TX-100 and 3 mg/ml of membranes.
We estimated the amount of receptors in P obtained from the two
series of experiments, in which M was treated with 0.1% or 0.3% TX-
100 (Fig. 8). Almost 30% of the initial DOR⁎ amount was retrieved in P
if 0.1% TX-100 is used. It decreased to 23% with 0.3% or 1% of TX-100,
suggesting that total solubilisation of DOR⁎was never observed. P was
then subjected to a density gradient. The percentages of initial DOR⁎
in LDFP and in SPP using the lowest concentration of TX-100 are 5% and
24%, respectively, and not detectable ﬂuorescence was observed in
(F6–11)P. At a concentration of 0.3% TX-100, only 3% of receptors were
measured in LDFP and increasing detergent concentration causes the
loss of the receptor from LDFP; however, 14% of receptors were still
present in the SPP fraction (Fig. 8). These last results are in agreement
with data obtained with Procedure 2: DOR⁎was observed in (F6–11)TM,
in SPTM and was only detectable in LDFTM if a low TX-100 con-
centration (0.1%) was used (data not shown).Fig. 8. Percentage of total DOR⁎ in DRMs isolated, according to the Procedure 1. eGFP
ﬂuorescence was estimated in P, LDFP and SPP and correlated with a quantity of initial
DOR⁎, as described in Fig. 3. The bars corresponded to: 1) M membranes solubilised
with 0.1% of TX-100, 2) M membranes were solubilised with 0.3% of TX-100, 3)
M membranes solubilised with 0.1% of TX-100+DEL II, 4) M membranes were solu-
bilised with 0.1% of TX-100+DPN, 5) M membranes solubilised with 0.1% of TX-100+
DEL II+ GppNHp, and 6) M membranes solubilised with 0.1% of TX-100+GppNHp. The
data represented the mean of two independent experiments.
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regulating its function. We then studied the effect of ligand addition
and of GppNHp addition on DOR⁎ partitioning; this was carried out by
resuspending M membranes, before and during cold extraction, in
buffer containing an excess of either Del2 or DPN, in the absence or
presence of GppNHp. We measured the amount of receptors in LDFP
and SPP in these cases (Fig. 8). Del2 treatment led to a two-fold increase
in the amount of DOR⁎ in LDFP (5% to 10%), whereas no change was
detected in SPP. This last result was conﬁrmed by checking the effect of
adding Del2 on the amount of DOR⁎ in P, assuming that SPP contains
more DOR⁎ than LDFP: no modiﬁcation of the P content was observed
upon the addition of ligand. In addition, Del2 systematically resulted in
an increased amount of DOR⁎ in LDFTM, as analysed using Procedure 2
(data not shown). However the addition of GppNHp prevented any
redistribution of DOR⁎ (Fig. 8), suggesting that G-protein coupling is
required in LDFP or LDFTM enrichment. Also, no difference in
ﬂuorescence was observed in P, in LDFP or in SPP after the addition of
DPN.
4. Discussion
The purpose of our study was to investigate the correlation
between DOR⁎ activity and its localisation in cholesterol-enriched
microdomains.
4.1. Characteristics of DRMs isolated by various procedures
We investigated the presence of cholesterol-enriched microdo-
mains in HEK membranes using two extraction methods based on
their cold TX-100 insolubility (Procedure 1, or Procedure 2). If we
compare the protein and lipid content of P with LDFTM and SPTM, we
observe that the protein content of LDFTM and SPTM is in fact derived
from P. Finally, Procedure 1 appears to be the best approach for
analysing soluble (S) and insoluble (LDFP, SPP) materials.
Overall, our results show that unsolubilised membranes (P, LDF, SP
comparedwith S)were enriched in cholesterol and sphingomyelin.We
observed an increase in these lipid species with the use of increasing
TX-100 concentrations. Detergent insolubility was also observed in
this study, consistent with previous reports [4]: it may be explained by
the existence of microdomains with various physico-chemical proper-
ties, allowing speciﬁc and distinct intermolecular interactionswith the
detergent, thus resulting in the differential solubilisation of these
microdomains. In the lo phase microdomain, the properties of
detergent resistance are attributed to close packing of saturated acyl-
chains of sphingolipids stabilized by cholesterol. Recent experiments
clearly indicate that the use of TX-100 provides the ability to dis-
tinguish between the ld and lo lipid phases by selectively solubilising
the ld phase, yet lo domains may be contaminated with additional
lipids from the ld phase [14]. In our study, the experiments support the
existence of sphingomyelin-rich and cholesterol-rich domains in HEK
membranes.
However, by DRM fractionation, insoluble material was isolated in
LDF but also in SP, and the percentage of protein in LDF (2–5% of the
protein content) appeared to be signiﬁcantly lower than that in SP
(50–70% of the protein content). Similar observations were made with
membranes of CHO cells expressing hMOR (Gaibelet et al., submitted
manuscript). In another study whose aim was to characterise micro-
domains of mouse thymocytes using Brij 98 at 37 °C, 2.5% of total
protein was detected in low-density detergent-insoluble membranes
[39]. We observed that PLAPwas also associated with LDFTM and SPTM,
with higher levels of enrichment in the LDFTM than in the SPTM. Taken
together these data indicated that LDF and SP exhibit classic bio-
chemical raft characteristics.
Few studies have reported unsolubilisedmaterial in SP. Cytoskeleton
elements were thought to be responsible for the insolubility of these
particular membranes [40,41]. However, it must be emphasised that (i)actin cytoskeletonmay be prominent in constructing rafts [42]; also, (ii)
actin has been shown to be associatedwithDRMs of lowdensity, if a low
detergent concentration is used, and it has been found sedimented in
the sucrose-pellet after the detergent concentrationwas increased. The
data also suggested that high density fractions contain bothnon-raft and
raft materials [15]. Furthermore, even if rafts are classically deﬁned as a
domain of low density, reported rafts do not appear to be identical in
terms of their protein or lipid content, and are dependent on the type
and concentration of thedetergent used and on the cell type. Also, DRMs
of various compositions can be generated from the same starting
material using one simple non-ionic detergent and a graded extraction
of membrane-associated proteins, in which protein-raft markers are
observed by increasing detergent concentrations [15]. Indeed, it is likely
that a given protein can associate with rafts with various kinetics or
partition coefﬁcients. As a consequence, the solubilisationmay be based
not only on their differential spatial distributionwithin raft and non-raft
microdomains, but also on their individual chemical properties [13].
Thus, lipid raft isolation that does not involve detergent extraction has
been developed to assess the possible introduction of artefacts through
detergent use [43]. Interestingly, both procedures result in similar con-
clusions, yieldingmembrane fractions of low density, highly enriched in
cholesterol, glycosphingolipids and a variety of proteins thought to be
protein-raft markers [44].
Finally, the reported variability in DRM composition could be ex-
plained by the co-existence of multiple, distinct, co-existing raft
domains within the plasma membrane [1]. In our study where LDF
exhibited classic biochemical raft characteristics, it is difﬁcult to consider
that all proteins in SP (~70%) constitute pre-existing raft proteins. SP
appears to be more of an aggregate of proteins containing raft markers
and would correspond to membrane domains which were disrupted.
These data suggest that detergent extraction does not allow the
separation of all the various lipid domains. Many studies have sought
to characterise DRMs, but deﬁning the best conditions to speciﬁcally
extract maximum rafts appears to be difﬁcult [15].
4.2. DOR⁎ partitioning
No signiﬁcant and reproducible binding activity was observed in
the various fractions obtained, using our solubilisation and DRMs
fractionation conditions (according to Procedure 1 or 2). Fortunately,
eGFP allowed us quantitative steady-state ﬂuorescence measure-
ments of DOR⁎ in the membrane fractions (M, P, LDF and SP). This
approach shows its efﬁciency in the quantiﬁcation of eGFP-labelled
DOR in various membrane samples analysed.
Overall, in the HEK membranes, we found that N70% of the initial
pool of DOR⁎ can be extracted by TX-100; however, it is only with the
lowest TX-100 concentrations that DOR⁎ appeared to be associated
with LDF. The addition of DPN and GppNHp had no effect on the DOR⁎
distribution between DRMs and non-DRMs, but a two-fold increase of
DOR⁎ content in LDFP was induced by Del2, and was prevented by the
addition of GppNHp. These data suggest that the form able to shift
into LDF is the high afﬁnity state form, stabilized by its interaction
with G-protein [45].
In contrast to our results, a recent study using a detergent-free
method has shown that about 70% of DOR are present in DRMs of low
density. Furthermore, stimulation with full agonist, but not with
partial or inverse agonists, shifts 25% of DOR out of the rafts [46].
However, the method used replaces non-ionic detergent with a high
pH sodium carbonate buffer, a protocol previously proposed for the
isolation of caveolae.
Caveolae are morphologically and biochemically characterised
[47–49]. They appear to exist predominantly at the cell surface as
independent and deﬁned structures [50]. It would seem that mem-
brane lipid rafts could be precursors of caveolae, but caveolae have
other speciﬁc precursor proteins, such as caveolin, and cannot be
deﬁned as rafts.
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they observed a dynamic recruitment of hDOR upon agonist binding
from the PC-rich to the SM-rich domain in a planar-supported bilayer
composed of a PC/SM mixture. Also, hDOR trafﬁcking with antagonist
treatment was 2-fold lower than that with agonist treatment.
4.3. Characteristics of DOR⁎ binding activity and modulation of this
activity by the membrane cholesterol content
After MβCD cholesterol depletion, we observed that DPN and Del2
Bmax values and also the amount of agonist-induced [35S]-GTPγS
incorporation decreased gradually with a decrease in the cholesterol
content. These experiments support a regulatory role for cholesterol
in DOR⁎ activity. It is clear that cholesterol plays an important role in
modulating several GPCRs functions. An increase in the amount of
cholesterol has an inhibitory effect on rhodopsin function [51]. By
contrast, several GPCRs appear to require cholesterol for agonist
binding function [52]. Experiments with the hippocampal serotonin-
1A receptor demonstrate that the reduction of membrane cholesterol
content signiﬁcantly attenuates not only agonist binding but also its
antagonist binding function [53]. This was also the case for DOR⁎ in
this study. Furthermore, this effect can be reversed and the decrease in
Bmax is not due to the loss of receptors from the plasma membrane
(eGFP ﬂuorescent measurements). Overall, our experiments show that
almost 60% of the total receptor, in which 15% is in high afﬁnity state,
required cholesterol for binding activity (Table 1). They suggest the
existence of at least four pools of DOR⁎ (Bmaxb Table 1): Two pools
requiring the presence of cholesterol for a conformation able to bind
its ligand (agonist and antagonist): (i) one pool in high afﬁnity state
(∼15%) and (ii) one pool in low afﬁnity state (∼45%). Two others pools
which may be stabilized in a cholesterol-poor environment: (i) one
pool in high afﬁnity state (∼15%) and (ii) one pool in low afﬁnity state
(∼25%). Moreover, experiments carried out in the presence of
GppNHp destabilized the equilibrium between the two forms (high
and low afﬁnity state). They showed that, if the membrane contained
8% Chol/PL, only 5% of DOR⁎ content is bound by Del2. Taken together
these data suggest that G-proteins stabilize a high afﬁnity state
conformation which does not seem modulated by cholesterol. More-
over, the incorporation of GTP upon agonist binding is modulated
by cholesterol content. To explain these results we propose that a
fraction of agonist-activated receptor forms requires a cholesterol-rich
environment.
The existence of two pools of functional receptors stabilized by a
different particular lipid membrane environment could explain that
everyGPCRactivatesmultiple effectors via coupling todistinctG-proteins.
Thus, the current model suggests that isomerisation of receptors upon
agonist binding do not only give one active state, but rather at least two
active states, each of which interacts with distinct G-proteins trig-
gering different effector pathways [54,55]. Some studies [49] report
also that G-proteins target discrete and distinct cell surface micro-
domains: Gq especially concentrates in caveolae, whereas Gi and Gs
concentrate much more in lipid rafts. Indeed, a possible mechanism is
that the receptor adopts various conformations in constitutive or active
state, each of them requiring a particular lipid environment for speciﬁc
G-protein interaction.
Likewise, assuming that the pool of DOR⁎modulated by cholesterol
(60%) is related to its localisation in cholesterol-enriched micro-
domains,we askwhether a pool of receptors could be recruited to rafts.
Under the conditions of DRMs isolation, only less than a 30%of the total
initial pool of DOR⁎ could be isolated in cholesterol/sphingomyelin-
enriched fractions, i.e. half of that expected. To understand these
discrepancies, it should be noted that although domains isolated after
TX-100 solubilisation contain pre-existing lo domains, they do not
entirely represent existing domains in their native state [14], and we
showed that the raft markers and DOR⁎ proportions recruited in these
cholesterol-rich and sphingomyelin-rich fractions depend on deter-gent/lipid ratios. Interestingly, DRM isolation demonstrated a two-fold
increase in DOR⁎ content upon agonist binding, in the low-density
cholesterol/sphingomyelin-enriched fraction (LDFp); this can be
clearly ascribed to rafts microdomains and our data suggest that this
fraction recruited in LDFP upon Del2 binding might be a G-protein
coupled form of the receptor. These ﬁndings are consistent with our
previous purposes: a pool of constitutively G-protein coupled
receptors is in a poor cholesterol environment and need a choles-
terol-rich environment upon agonist binding.
5. Conclusion
In light of the signiﬁcance of the existence of rafts, there are still
open questions: (i) what is the driving force for sequestering the
receptor into various lipid microdomains? Various factors involved in
the sorting of proteins to speciﬁc microdomains have been suggested
[44]: speciﬁc interactions with lipids (cholesterol) may be involved for
some proteins [56]. One would also expect that the trans-bilayer
pressure of each microdomain can control the conformational
equilibrium of proteins [57]. Another issue is hydrophobic matching
between the transmembrane domains of the protein and the lipid
environment. In this context, to explain our data, we propose that the
stabilization of each DOR⁎ form may be achieved via a mechanism of
protein sorting. We assume that cholesterol, in proportion to its local
concentration, promotes microdomains with distinct thicknesses; the
hydrophobic matching principle could be a driving force involved in
lipid and protein sorting. Thus, our results suggest that the DOR⁎
structure adapts oneself in each microdomain. The elongated DOR⁎
forms, induced upon Del2 binding [20], require a rearrangement of the
lateral distribution of molecules to stabilize these new DOR⁎
conformations. The variation in the total cholesterol concentration
modulates thesemolecular distributions and adaptations, likewise the
activity of DOR⁎ forms.We plan to test this hypothesis by investigating
the effect of the acyl-chain length of the phospholipids on the function
and lateral distribution of the reconstituted DOR⁎.
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